AstraZeneca
The Regulatory Intelligence Director leads the analysis and impact assessment of regulatory and competitive intelligence for AstraZeneca's Respiratory and Immunology portfolio, translating emerging signals into strategic decisions for pipeline and marketed assets. The role collaborates with senior regulatory leaders, cross‑functional intelligence groups, and global regulatory bodies to identify opportunities, guide development pathways, and communicate insights to senior stakeholders.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
Regulatory Policy and Intelligence Fellow
Digital Biology
Senior Director, Global Regulatory Lead Neuroscience
Bristol Myers Squibb
Global Regulatory Affairs (GRA) Device Lead
UCB
Global Regulatory Affairs (GRA) Device Lead
UCB
Senior Director, Regulatory Affairs CMC – Biologics
Beeline Medicines
Manager Regulatory Intelligence
Zoetis